Cargando…
Chlorotoxin and Lung Cancer: A Targeting Perspective for Drug Delivery
In the generational evolution of nano-based drug delivery carriers, active targeting has been a major milestone for improved and selective drug accumulation in tissues and cell types beyond the existing passive targeting capabilities. Among the various active targeting moieties, chlorotoxin, a pepti...
Autores principales: | Shrestha, Archana, Lahooti, Behnaz, Mikelis, Constantinos M., Mattheolabakis, George |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9786857/ https://www.ncbi.nlm.nih.gov/pubmed/36559106 http://dx.doi.org/10.3390/pharmaceutics14122613 |
Ejemplares similares
-
MiRNAs as Anti-Angiogenic Adjuvant Therapy in Cancer: Synopsis and Potential
por: Lahooti, Behnaz, et al.
Publicado: (2021) -
Nanoparticle Delivery and Tumor Vascular Normalization: The Chicken or The Egg?
por: Mattheolabakis, George, et al.
Publicado: (2019) -
Chlorotoxin-conjugated graphene oxide for targeted delivery of an anticancer drug
por: Wang, Hao, et al.
Publicado: (2014) -
Multipronged activity of combinatorial miR-143 and miR-506 inhibits Lung Cancer cell cycle progression and angiogenesis in vitro
por: Hossian, A. K. M. Nawshad, et al.
Publicado: (2018) -
Chlorotoxin-conjugated onconase as a potential anti-glioma drug
por: WANG, XIAOMIN, et al.
Publicado: (2015)